Skip to main content
Watch Insiders
PCRXHealthcare

Pacira BioSciences Inc (PCRX) Insider Trading

In the last 90 days, 2 Pacira BioSciences Inc (PCRX) insiders reported no open-market purchases and 2 sales totaling $288,539. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 8, 2026Lauren RikerSenior Vice President, FinanceSale6,000$36.32$217,920
Aug 17, 2026Jonathan SloninChief Medical OfficerSale3,040$23.23$70,619
Jun 11, 2026Lauren RikerSenior Vice President, FinanceSale6,115$23.50$143,703
Jun 4, 2026Kristen WilliamsChief Administrative OfficerSale10,259$22.27$228,468
Apr 23, 2026Shawn CrossChief Financial OfficerSale12,941$25.16$325,596
Apr 22, 2026Shawn CrossChief Financial OfficerSale12,059$25.09$302,599

Common questions

PCRX insider trading FAQ

Are PCRX insiders buying or selling?
Over the last 90 days, PCRX insiders were net sellers, reporting $0.00 of open-market purchases and $288,539 of sales.
When was the last PCRX insider purchase?
No open-market insider purchase of Pacira BioSciences Inc stock was reported in the last 90 days.
Where does PCRX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Pacira BioSciences Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.